Melatonin ameliorates nonalcoholic fatty liver induced by high-fat diet in rats

Journal of Pineal Research

Volumn 41, Issue 1, 2006, Pages 79-84

  Pan, Min ^a   Song, Yu Lin ^a   Xu, Jian Ming ^a   Gan, Hui Zhong ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

Antioxidants; Lipid peroxidation; Melatonin; Nonalcoholic fatty liver; Oxidative stress; Steatosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CHOLESTEROL; EOSIN; GLUTATHIONE PEROXIDASE; HEMATOXYLIN; LIVER ENZYME; MALONALDEHYDE; MELATONIN; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL LIVER LEVEL; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DRUG EFFICACY; ENZYME ACTIVITY; EVALUATION; LIPID ANALYSIS; LIPID DIET; LIPID PEROXIDATION; LIVER CIRRHOSIS; LIVER FAILURE; LIVER FIBROSIS; LIVER INJURY; LIVER PROTECTION; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; RAT; STAINING;

ANIMALS; DIETARY FATS; FATTY LIVER; GLUTATHIONE PEROXIDASE; LIPID PEROXIDATION; LIVER; MALE; MALONDIALDEHYDE; MELATONIN; OXIDATIVE STRESS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE;

EID: 33745581994     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2006.00346.x     Document Type: Article

References (49)

1. REID A. Nonalcoholic steatohepatitis. Gastroenterology 2001; 121:710-723.
2. ANGULO P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346:1221-1231.
3. FONG DG, NEHRA V, LINDOR KD et al. Metabolic and nutritional considerations in nonalcoholic fatty liver. Hepatology 2000; 32:3-10.
4. CLARK JM, BRANCATI FL, DIEHL AM. Nonalcoholic fatty liver disease. Gastroenterology 2002; 122:1649-1657.
5. KORUK M, TAYSI S, SAVAS MC et al. Oxidative stress and enzymatic antioxidant status in patients with nonalcoholic steatohepatitis. Ann Clin Lab Sci 2004; 34:57-62.
6. VDELA LA, RODRIGO R, ORELLANA M et al. Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients. Clin Sci (Lond) 2004; 106:261-268
7. TAN DX, MANCHESTER LC, HARDELAND R et al. Melatonin: a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin. J Pineal Res 2003; 34:75-78.
8. BRZEZINSKI A. Melatonin in humans. N Engl J Med 1997; 336:186-195.
9. REITER RJ, TAN DX, ACUNA-CASTROVIEJO D et al. Melatonin: mechanisms and actions as an antioxidant. Curr Topics Biophys 2000; 24:171-183.
10. REITER RJ. Melatonin: lowering the high price of free radicals. News Physiol Sei 2000; 15:246-250.
11. FOLCH J, LEES M, STANLEY GHS. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957; 226:497-509.
12. SHIMIZU I, MA YR., MIZOBUCHI Y et al. Effects of Sho-saikoto, a Japanese herbal medicine, on hepatic fibrosis in rats. Hepatology 1999; 29:149-160.
13. BRUNT EM, JANNEY CG, BISCEGLIE AM et al. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94:2467-2474.
14. WEST DB, YORK B. Dietary fat, genetic predisposition and obesity. Lessons from animal models. Am J Clin Nutr 1998; 67:505S-512S.
15. LIEBER SC, LEO MA, MAK KM et al. Model of nonalcoholic steatohepatitis. Am J Clin Nutr 2004; 79:502-509.
16. ANGULO P, LINDOR KD. Insulin resistance and mitochondrial abnormalities in NASH: a cool look at a burning issue. Gastroenterology 2001; 120:1281-1285.
17. CRUZ A, PADILLO FJ, TORRES E et al. Melatonin prevents experimental liver cirrhosis induced by thioacetamide in rats. J Pineal Res 2005; 39:143-150.
18. OHTA Y, KONGO-NISHIMURA M, MATSURA T et al. Melatonin prevents disruption of hepatic reactive oxygen species metabolism in rats treated with carbon tetrachloride. J Pineal Res 2004; 36:10-17.
19. WANG H, WEI W, WANG NP et al. Melatonin ameliorates carbon tetrachloride-induced hepatic fibrogenesis in rats via inhibition of oxidative stress. Life Sci 2005; 77:1902-1915.
20. TAHAN V, OZARAS R, CANBAKAN B et al. Melatonin reduces dimethylnitrosamine-induced liver fibrosis in rats. J Pineal Res 2004; 37:78-84.
21. XU DX, WEI W, SUN MF et al. Melatonin attenuates lipopolysaccharide- induced down-regulation of pregnane X receptor and its target gene CYP3A in mouse liver. J Pineal Res 2005; 38:27-34.
22. ABDEL-WAHHAB MA, ABDEL-GALIL MM, EL-LITHEY M. Melatonin counteracts oxidative stress in rats fed an ochratoxin A contaminated diet. J Pineal Res 2005; 38:130-135.
23. EL-SOKKARY GH, ABDEL-RAHMAN GH, KAMEL ES et al. Melatonin protects against lead-induced hepatic and renal toxicity in male rats. Toxicology 2005; 213:25-33.
24. PAL S, CHATTERJEE AK. Prospective protective role of melatonin against arsenic-induced metabolic toxicity in Wistar rats. Toxicology 2005; 208:25-33.
25. SEWERYNEK E, REITER RJ, MELCHIORRI D et al. Oxidative damage in the liver induced by ischemia-reperfusion: protection by melatonin. Hepatogastroenterology 1996; 43:898.
26. OHTA Y, KONGO M, KISHIKAWA T. Melatonin exerts a therapeutic effect on cholestatic liver injury in rats with bile duct ligation. J Pineal Res 2003; 34:119-126.
27. SENER G, BALKAN J, CEVIKBAS U et al. Melatonin reduces cholesterol accumulation and prooxidant state induced by high cholesterol diet in the plasma, the liver and probably in the aorta of C57BL/6J mice. J Pineal Res 2004; 36:212-216.
28. SAHNA E, PARLAKPINAR H, VARDI N et al. Efficacy of melatonin as protectant against oxidative stress and structural changes in liver tissue in pinealectomized rats. Acta Histochem 2004; 106:331-336.
29. TAN DX, CHEN DX, POEGGELER B et al. Melatonin: a potent endogenoushydroxyl radical scavenger. Endocr J 1993; 1:57-60.
30. TAN DX, POEGGELER B, REITER RJ et al. The pineal hormone melatonin inhibits DNA-adduct formation induced by the chemical carcinogen safrole in vivo. Cancer Lett 1993; 70:65-71.
31. STEINHILBER D, BRUNOS M, WERZ O et al. The nuclear receptor for melatonin repress 5-lipoxygenase gene expression in human B lymphocytes. J Biol Chem 1995; 270:7037-7040.
32. ANGULO P, KEACH JC, BATTS KP et al. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999; 30:1356-1362.
33. AOYAMA H, MORI N, MORI W. Effects of melatonin on genetic hypercholesterolemia in rats. Atherosclerosis 1988; 69:269-272.
34. MORI N, AOYAMA H, MURASE T et al. Anti-hypercholesterolemic effect of melatonin in rats. Acta Pathol Jpn 1989; 39:613-618.
35. CHAN TY, TANG PL. Effect of melatonin on the maintenance of cholesterol homeostasis in the rat. Endocrinol Res 1995; 21:681-696.
36. HOYOS M, GUERRERO JM, PERZE-CANO R et al. Serum cholesterol and lipid peroxidation are decreased by melatonin in diet-induced hypercholesterolemic rats. J Pineal Res 2000; 28:150-155.
37. MULLER-WIELAND D, BEHNKE B, KOOPMANN K et al. Melatonin inhibits LDL receptor activity and cholesterol synthesis in freshly isolated human mononuclear leucocytes. Biochem Biophys Res Commun 1994; 202:416-421.
38. BRYDON L, PETIT L, DELAGRANCE P et al. Functional expression of MT2 (Mel 1b) melatonin receptors in human PAZ 6 adipocytes. Endocrinology 2001; 142:4264-4271.
39. ALONSO-VALE MIC, ANDREOTTI S, ERES SB et al. Melatonin enhances leptin expression by rat adipocytes in the presence of insulin. Am J Physiol Endocrinol Metab 2005; 288:805-812.
40. ROBERTSON G., LECLERCQ I, FARRELL GC. Nonalcoholic steatosis and steatohepatitis: II. Cytochrome P-450 enzymes and oxidative stress. Am J Physiol Gastrointest Liver Physiol 2001; 281:G1135-G1139.
41. BROWNING JD, HORTON JD. Molecular mediators of hepatic steatosis and liver injury. J Clin Invest 2004; 114:147-152.
42. CHITTURI S, FARRELL GC. Etiopathogenesis of nonalcoholic steatohepatitis. Semin Liver Dis 2001; 21:27-41.
43. ESTERBAUER H, SCHAUR RJ, ZOLLNER H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991; 11:81-128.
44. ABDELMALEK MF, ANGULO P, JORGENSEN RA et al. Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study. Am J Gastroenterol 2001; 96:2711-2717.
45. GULBAHAR O, KARASU ZA, ERSÖZ G. Treatment of non-alcoholic steatohepatitis with N-acetylcysteine. Gastroenterology 2000; 118:1444A.
46. LAVINE JE. Vitamin E treatment of nonalcoholic steatohepatitis in children: a pilot study. J Pediatr 2000; 136:734-738.
47. LEON J, ACUNA-CASTROVIEJO D, ESCAMES G et al. Melatonin mitigates mitochondrial malfunction. J Pineal Res 2005; 38:1-9.
48. MARKOVÁ M, ADÁMEKOVÁ E, KUBATKA B et al. Effect of prolonged melatonin administration on metabolic parameters and organ weights in young male and female Sprague-Dawley rats. Acta Vet Brno 2003; 72:163-173.
49. WOLDEN-HANSON T, MITTON DR, MCCANTS RL et al. Daily melatonin administration to middle-aged male rats suppresses body weight, intraabdominal adiposity, and plasma leptin and insulin independent of food intake and total body fat. Endocrinology 2000; 141:487-497.